The American Journal of Managed Care16h
Redefining Functional Measures in SMA: Insights From Clinical Research
The evolution of functional assessments for spinal muscular atrophy (SMA) highlights the challenges of adapting pediatric ...
Macleans.ca1d
How Patients Living With Spinal Muscular Atrophy Can Achieve More Through Active Living
Exercise can make a significant difference for patients with SMA by working alongside other medical advancements to improve ...
Medpage Today on MSN3d
First-Ever Prenatal Treatment for Spinal Muscular Atrophy Shows Promise
The first prenatal therapy for spinal muscular atrophy (SMA) showed promising results, a case report indicated. More than 2 ...
Medindia1d
Risdiplam: First In-Utero Treatment for Spinal Muscular Atrophy
Discover the first in-utero treatment for spinal muscular atrophy (SMA) using risdiplam. Promising results show no SMA signs ...
Monthly Prescribing Reference3d
New Tablet Formulation of SMA Therapy Evrysdi Gets FDA Approval
The tablet formulation can either be swallowed whole or dispersed in a teaspoon of filtered (non-chlorinated) water.
FDA Approves New Tablet Form of Evrysdi for Treatment of Spinal Muscular Atrophy
The Muscular Dystrophy Association celebrates this new more accessible treatment option for people living with SMA. MDA - New ...
FiercePharma9d
Roche scores FDA nod for Evrysdi tablets, bolstering convenience edge over rivals
Over the past nine years, patients with spinal muscular atrophy have seen the number of FDA-approved treatment options for ...
Business Wire9d
FDA Approves Genentech’s Evrysdi Tablet as First and Only Tablet for Spinal Muscular Atrophy (SMA)
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the U.S. Food and Drug Administration (FDA) has approved a New ...